| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/29/2006 | US7097829 Transgenic cells transfected with pituitary tumor transforming gene (PTTG)) expression vectors and uses therefor |
| 08/29/2006 | CA2111238C Production of a protein of interest in the milk of a transgenic mammal |
| 08/29/2006 | CA2053585C Antibody production in chinese hamster ovary cells |
| 08/24/2006 | WO2006088867A2 Method for expansion of stem cells |
| 08/24/2006 | WO2006088747A2 Serum-free reagents for the isolation, cultivation, and cryopreservation of postnatal pluripotent epiblast-like stem cells |
| 08/24/2006 | WO2006088700A2 Human ring specific bnp antibodies |
| 08/24/2006 | WO2006088494A2 Identification and engineering of antibodies with variant fc regions and methods of using the same |
| 08/24/2006 | WO2006088219A1 Il-13 production inhibitor |
| 08/24/2006 | WO2006088198A1 Method of producing protein by using hamster igf-1 |
| 08/24/2006 | WO2006088154A1 Method and apparatus for separating cells |
| 08/24/2006 | WO2006088110A1 Novel protein promoting carbonic acid fixation and method of fixing carbonic acid by using the protein |
| 08/24/2006 | WO2006088029A1 Method of producing high-density cultured tissue and high-density cultured tissue |
| 08/24/2006 | WO2006087756A2 Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity |
| 08/24/2006 | WO2006087624A1 Pharmaceutical composition and relative use for the treatment and prevention of prostate tumour |
| 08/24/2006 | WO2006087243A1 Production of recombinant proteins in synthetic medium |
| 08/24/2006 | WO2006087220A2 Receptacle for the separation of tumor cells |
| 08/24/2006 | WO2006086838A1 Flavivirus replicon constructs for tumour therapy |
| 08/24/2006 | WO2006069413A3 Method for isolating cells and viruses |
| 08/24/2006 | WO2006065827A9 Cell lines for production of replication-defective adenovirus |
| 08/24/2006 | WO2006065827A2 Cell lines for production of replication-defective adenovirus |
| 08/24/2006 | WO2006055940A3 Block copolymers of polycaprolactone and poly (propylene fumarate) |
| 08/24/2006 | WO2006051418A3 Transcription factor of the zn binuclear cluster family of fungal regulators |
| 08/24/2006 | WO2006050330A3 Platelets from stem cells |
| 08/24/2006 | WO2006050213A3 Methods of promoting healing of cartilage defects and method of causing stem cells to differentiate by the articular chondrocyte pathway |
| 08/24/2006 | WO2006048783A8 Autogenic living scaffolds and living tissue matrices: methods and uses thereof |
| 08/24/2006 | WO2006047635A3 Methods and compositions for seprase inactivation |
| 08/24/2006 | WO2006047233A3 Pink-1 promoter |
| 08/24/2006 | WO2006040763A3 Isolated primate embryonic cells and methods of generating and using same |
| 08/24/2006 | WO2006039678A3 Establishment of highly metastatic cell lines using nog mice |
| 08/24/2006 | WO2006039621A3 Novel modification of immunomodulatory protein |
| 08/24/2006 | WO2006038128A3 Citrobacter freundii phytase and homologues |
| 08/24/2006 | WO2006016808A3 Means and methods for producing a stabilized cell of interest |
| 08/24/2006 | WO2006013388A3 Materials and methods for modulating signalling by alpha-v integrin molecules |
| 08/24/2006 | WO2006010558A8 Tumor-homing cells engineered to produce tumor necrosis factor-related apoptosis-inducing ligand (trail) |
| 08/24/2006 | WO2006007375A3 Use of bridge-1 and activators and inhibitors thereof in the treatment of insulin deficiency and diabetes |
| 08/24/2006 | WO2006004768A3 Immortal cell lines containing non-mitochondrial genetic material within the mitochondria |
| 08/24/2006 | WO2005109991A8 Anti-theileriosis vaccine |
| 08/24/2006 | WO2005030134A3 Relationship of a specific metabolite to insulin resistance |
| 08/24/2006 | WO2005018540A3 Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants |
| 08/24/2006 | WO2004113507A9 Pharmaceutically compatible method for purifying intact bacterial minicells |
| 08/24/2006 | WO2004065618A3 Methods and devices for monitoring cellular metabolism in microfluidic cell-retaining chambers |
| 08/24/2006 | WO2004043397A3 Compositions and methods for the treatment of rheumatoid arthritis |
| 08/24/2006 | US20060191047 Cotton variety FM 800B2R |
| 08/24/2006 | US20060191046 Cotton variety FM 960B2R |
| 08/24/2006 | US20060191045 Cotton variety FM 991B2R |
| 08/24/2006 | US20060191044 DNA comprises the nucleotide sequences used for gene expression of foreign proteins in seeds; genetic engineering |
| 08/24/2006 | US20060191042 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids |
| 08/24/2006 | US20060191041 DWF4 polynucleotides, polypeptides and uses thereof |
| 08/24/2006 | US20060191040 For altering trehalose-6-phosphate phosphatase activity in a plant; for temporal and spatial expression in transgenic plants to alter plant morphology and affect yield in plants; stress tolerance |
| 08/24/2006 | US20060191039 Methods and compositions for protein production in tobacco plants with reduced nicotine |
| 08/24/2006 | US20060191037 Plant transcription factor that is involved in sugar signalling |
| 08/24/2006 | US20060191036 Growing a tobacco plant having cells that contain an exogenous DNA sequence that encodes quinolate phosphoribosyl transferase functional in the cells |
| 08/24/2006 | US20060191035 Methods and compositions for protein production in tobacco plants with reduced nicotine |
| 08/24/2006 | US20060191033 Novel glyphosate-N-acetyltransferase (GAT) genes |
| 08/24/2006 | US20060191032 Soybean cultivar 4713487 |
| 08/24/2006 | US20060191031 Soybean cultivar 4348019 |
| 08/24/2006 | US20060191030 Soybean cultivar S040122 |
| 08/24/2006 | US20060191027 Cystine-knot polypeptides: Cloaked-2 molecules and uses thereof |
| 08/24/2006 | US20060191024 Method for preparing anti-MIF antibodies |
| 08/24/2006 | US20060189785 Using biocompatible, low molecular weighty, water solubler polymer; injectable |
| 08/24/2006 | US20060189562 In vitro-differentiated retinal ganglion cells and method for producing same |
| 08/24/2006 | US20060189538 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof |
| 08/24/2006 | US20060189531 Thrombopoietic compounds |
| 08/24/2006 | US20060189530 Neuropeptide Y receptor Y5 and nucleic acid sequences |
| 08/24/2006 | US20060189525 DADD, death activator death domain protein |
| 08/24/2006 | US20060189520 Treatment of diabetes |
| 08/24/2006 | US20060188988 Optimized high yield synthetic plasmids |
| 08/24/2006 | US20060188987 Targeted deletion of cellular DNA sequences |
| 08/24/2006 | US20060188986 Restoration of methylation states in cells |
| 08/24/2006 | US20060188985 Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair |
| 08/24/2006 | US20060188984 Method of providing readily available cellular material derived from cord blood, and a composition thereof |
| 08/24/2006 | US20060188983 Homogeneity culture product; promotes cell differentiation; cardiovascular disorders |
| 08/24/2006 | US20060188982 Multiplexed analysis for determining a serodiagnosis of viral infection |
| 08/24/2006 | US20060188975 Genetically modified somatic cells for sustained secretion of lysosomal proenzymes deficient in lysosomal storage disorders |
| 08/24/2006 | US20060188963 Collectin-complement activating protein chimeras |
| 08/24/2006 | US20060188962 19 human secreted proteins |
| 08/24/2006 | US20060188957 Novel TNF receptor death domain ligand proteins and inhibitors of ligand binding |
| 08/24/2006 | US20060188923 Novel human parvovirus B19 receptor and uses thereof |
| 08/24/2006 | US20060188914 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/24/2006 | US20060188867 Method of cryopreserving cells and tissues by liposomal delivery of sugars to enhance post-thaw viability |
| 08/24/2006 | US20060188544 Periodontal tissue regeneration using composite materials comprising phosphophoryn |
| 08/24/2006 | US20060188521 Disrupting sex steroid signal to thymus: bone marrow or hematopoietic cells |
| 08/24/2006 | US20060188516 Chlamydia trachomatis antigens |
| 08/24/2006 | US20060188502 Nucleic acid encoding a chimeric, humanized or CDR-grafted antibody that binds and inhibits the activity of human IL-6 |
| 08/24/2006 | US20060188491 Use of nuclear material to therapeutically reprogram differentiated cells |
| 08/24/2006 | US20060188489 Methods and materials for increasing potency of cells |
| 08/24/2006 | US20060188488 Prevascularized constructs for implantation to provide blood perfusion |
| 08/24/2006 | US20060188485 Autologous self-tolerance inducing cells of monocytic origin and their use in pharmaceutical preparations |
| 08/24/2006 | US20060188484 Virus vectors and methods of making and administering the same |
| 08/24/2006 | US20060188483 Virus vectors and methods of making and administering the same |
| 08/24/2006 | US20060188479 Plasmid for tissue targeted treatment of tumors; antitumor agents |
| 08/24/2006 | US20060188477 Use of interferon alpha 5 in the treatment of viral liver diseases |
| 08/24/2006 | US20060188473 Compositions and methods for repressing B cell autoantibody secretion and for treating autoimmune disorders |
| 08/24/2006 | DE60115613T2 Herstellung von rekombinanten muteine des blutgerinnungsfaktors viii in humanen zellinien Production of recombinant muteins of the blood coagulation factor viii in human cell lines |
| 08/24/2006 | CA2642274A1 Receptacle for the separation of tumor cells |
| 08/24/2006 | CA2599043A1 Method and apparatus for separating cells |
| 08/24/2006 | CA2598570A1 Methods for producing proteins using hamster igf-1 |
| 08/24/2006 | CA2598522A1 Human monoclonal antibodies to prostate specific membrane antigen (psma) |
| 08/24/2006 | CA2598403A1 Production of recombinant proteins in synthetic medium |
| 08/24/2006 | CA2598292A1 Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity |